23andMe (Acquisition)
Funding Details
Date Award
May 30, 2025
Vertical
Biopharma
Funding URL
View Funding Page
Funding Amount
$256,000,000
Company Info
Market
Healthcare
Location
USA
Company Description

23andMe is a biotechnology company that provides genetic testing services to consumers, allowing them to access information about their ancestry and health traits.

Links
Back to HomeBack to Biopharma DealsView Funding Announcement